Skip to main content
. 2017 Aug 10;12(8):e0182696. doi: 10.1371/journal.pone.0182696

Fig 2. OGT elevated O-GlcNAcylation on GNB2L1 in chemoresistant gastric cancer.

Fig 2

(A-B) The O-GlcNAcylation levels of GNB2L1 in different chemoresistant cells (A) and different tissue samples (B) were assessed via IP analysis, and protein levels of OGT and OGA were also determined via WB. Progressive disease (PD) was considered as chemoresistant; complete remission (CR), partial remission (PR) and stable disease (SD) as chemosensitive. GAPDH was used as loading control.(C-E) Correlation analysis of GNB2L1 levels with OGT (D) or OGA (E) in chemoresistant gastric cancer patients. Representative images (C) and statistical data (D-E) were shown. *, P<0.05.